BioCentury
ARTICLE | Financial News

Tessa raises additional $50M, names Ando to board

April 12, 2018 4:37 PM UTC

Immunotherapy company Tessa Therapeutics Pte. Ltd. (Singapore) added $50 million to a financing round announced in December, bringing the round's total to $130 million.

The company also named former Novo Nordisk A/S (CSE:NOVOB; NYSE:NVO) Chairman Göran Ando to its board as an independent director...